These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3426595)

  • 1. A human immunodeficiency virus type 1 (HIV-1) infection-enhancing factor in seropositive sera.
    Robinson WE; Montefiori DC; Mitchell WM
    Biochem Biophys Res Commun; 1987 Dec; 149(2):693-9. PubMed ID: 3426595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides.
    Palker TJ; Clark ME; Langlois AJ; Matthews TJ; Weinhold KJ; Randall RR; Bolognesi DP; Haynes BF
    Proc Natl Acad Sci U S A; 1988 Mar; 85(6):1932-6. PubMed ID: 2450351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-GP 120 antibodies from HIV seropositive individuals mediate broadly reactive anti-HIV ADCC.
    Lyerly HK; Reed DL; Matthews TJ; Langlois AJ; Ahearne PA; Petteway SR; Weinhold KJ
    AIDS Res Hum Retroviruses; 1987; 3(4):409-22. PubMed ID: 2833917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody-dependent enhancement of human immunodeficiency virus type 1 infection.
    Robinson WE; Montefiori DC; Mitchell WM
    Lancet; 1988 Apr; 1(8589):790-4. PubMed ID: 2895317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Broadly reactive antibody-dependent cellular cytotoxic response to HIV-1 envelope glycoproteins precedes broad neutralizing response in human infection.
    Koup RA; Pikora CA; Mazzara G; Panicali D; Sullivan JL
    Viral Immunol; 1991; 4(4):215-23. PubMed ID: 1726398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of cytotoxic antibody to human immunodeficiency virus-infected cells in humans and its induction in animals after infection or immunization with purified envelope glycoprotein gp120.
    Nara PL; Robey WG; Gonda MA; Carter SG; Fischinger PJ
    Proc Natl Acad Sci U S A; 1987 Jun; 84(11):3797-801. PubMed ID: 3473484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simple, rapid, quantitative, syncytium-forming microassay for the detection of human immunodeficiency virus neutralizing antibody.
    Nara PL; Hatch WC; Dunlop NM; Robey WG; Arthur LO; Gonda MA; Fischinger PJ
    AIDS Res Hum Retroviruses; 1987; 3(3):283-302. PubMed ID: 3481271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence of serological cross-reactivities with human immunodeficiency virus types 1 and 2 and human T-lymphotropic virus types I and II in sera of pregnant women in Ibadan, Nigeria.
    Olaleye DO; Ekweozor CC; Sheng Z; Rasheed S
    Int J Epidemiol; 1995 Feb; 24(1):198-203. PubMed ID: 7797344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutralizing antibodies and the course of HIV-induced disease.
    Wendler I; Bienzle U; Hunsmann G
    AIDS Res Hum Retroviruses; 1987; 3(2):157-63. PubMed ID: 3650100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variable and conserved neutralization antigens of human immunodeficiency virus.
    Weiss RA; Clapham PR; Weber JN; Dalgleish AG; Lasky LA; Berman PW
    Nature; 1986 Dec 11-17; 324(6097):572-5. PubMed ID: 2431324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restricted neutralization of divergent human T-lymphotropic virus type III isolates by antibodies to the major envelope glycoprotein.
    Matthews TJ; Langlois AJ; Robey WG; Chang NT; Gallo RC; Fischinger PJ; Bolognesi DP
    Proc Natl Acad Sci U S A; 1986 Dec; 83(24):9709-13. PubMed ID: 2432599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HTLV-III neutralizing antibody development in transfusion-dependent seropositive patients with beta-thalassemia.
    Robert-Guroff M; Giardina PJ; Robey WG; Jennings AM; Naugle CJ; Akbar AN; Grady RW; Hilgartner MW
    J Immunol; 1987 Jun; 138(11):3731-6. PubMed ID: 3495568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody-dependent cell-mediated cytotoxicity: comparison between HTLV-I and HIV-1 assays.
    Sinclair AL; Habeshaw JA; Muir L; Chandler P; Forster S; Cruickshank K; Dalgleish AG
    AIDS; 1988 Dec; 2(6):465-72. PubMed ID: 3149493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-neutralizing antibodies against cosmopolitan and Melanesian strains of human T cell leukemia/lymphotropic virus type I in sera from inhabitants of Africa and the Solomon Islands.
    Benson J; Tschachler E; Gessain A; Yanagihara R; Gallo RC; Franchini G
    AIDS Res Hum Retroviruses; 1994 Jan; 10(1):91-6. PubMed ID: 8179967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in the antibody response to human immunodeficiency virus-1 envelope glycoprotein (gp160) in infected laboratory workers and vaccinees.
    Pincus SH; Messer KG; Schwartz DH; Lewis GK; Graham BS; Blattner WA; Fisher G
    J Clin Invest; 1993 May; 91(5):1987-96. PubMed ID: 7683694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of an immunoglobulin preparation from HIV carriers in preventing HIV replication in vitro.
    Tochikura TS; Nakashima H; Uemura Y; Goto T; Suyama T; Kobayashi N; Yamamoto N
    Vox Sang; 1988; 54(3):138-43. PubMed ID: 3369135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement-dependent cytotoxic antibodies to human T lymphotropic virus type I (HTLV-I)-infected cells in the sera of HTLV-I-infected individuals.
    Plotnicky-Gilquin H; Afani A; Vernant JC; Desgranges C
    Clin Exp Immunol; 1996 Jul; 105(1):39-45. PubMed ID: 8697633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between HTLV-III neutralizing antibody and clinical status of pediatric acquired immunodeficiency syndrome (AIDS) and AIDS-related complex cases.
    Robert-Guroff M; Oleske JM; Connor EM; Epstein LG; Minnefor AB; Gallo RC
    Pediatr Res; 1987 Jun; 21(6):547-50. PubMed ID: 3474582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of a human immunodeficiency virus (HIV) immune globulin to protect chimpanzees against experimental challenge with HIV.
    Prince AM; Horowitz B; Baker L; Shulman RW; Ralph H; Valinsky J; Cundell A; Brotman B; Boehle W; Rey F
    Proc Natl Acad Sci U S A; 1988 Sep; 85(18):6944-8. PubMed ID: 3413127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection and titration of neutralizing antibodies to HIV using an inhibition of the cytopathic effect of the virus on MT4 cells.
    Rey F; Barré-Sinoussi F; Schmidtmayerova H; Chermann JC
    J Virol Methods; 1987 Jun; 16(3):239-49. PubMed ID: 3477567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.